Metastatic Colon Cancer Recruiting Phase 1 / 2 Trials for Pembrolizumab (DB09037)

Also known as: Colon cancer metastatic / Stage IV Colon Cancer / Colon cancer stage IV / Malignant neoplasm of colon stage IV / Colon cancer Duke's D / Malignant neoplasm of colon stage IV, unspecified

IndicationStatusPhase
DBCOND0033231 (Metastatic Colon Cancer)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02834052Pembrolizumab + Poly-ICLC in MRP Colon CancerTreatment